Search

everythinglearnresearchcommunity

for

Search:↓

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Minoxidil effectively treats female pattern hair loss.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

The document describes a treatment for excessive hair growth in a teenage girl using medication and birth control, but does not report the results.

Measuring the distance from the anus to the clitoris may moderately help diagnose polycystic ovary syndrome, especially in certain cases.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

The article suggests using safety measures and telemedicine for aesthetic dermatology during COVID-19, while some procedures can still be done safely.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

Common types of non-scarring hair loss have various causes and treatments, but more effective solutions are needed.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Women with acne have lower levels of a specific hormone marker than women without acne.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Hair loss affects women's self-esteem; treatments like minoxidil can help.

Acne in reproductive-age women may be linked to conditions like PCOS and lifestyle factors, so doctors should check for these when treating acne.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

AMH levels can't reliably tell the difference between LOCAH and all types of PCOS in women with excessive hair growth.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Fluridil promotes hair growth safely and effectively for androgenetic alopecia.

Chromium salts may help with insulin sensitivity in PCOS, but more research is needed to confirm their overall effectiveness and safety.

Most female students at Qassim University know about PCOS, but there are still misunderstandings about it.